Abstract
Objective. We assessed the performance of the Humasis COVID-19 AgHS Test (Humasis, Korea), a novel antigen rapid diagnostic test (Ag-RDT) based on lateral flow immunoassay. Methods. 85 SARS-CoV-2-positive and 155 SARS-CoV-2-negative nasopharyngeal swab specimens confirmed by rRTPCR were tested using the Humasis and PBCheck Ag-RDTs.The analytical specificity of the Humasis Ag-RDT was evaluated using 27 strains of human respiratory pathogens. Results. The overall sensitivity and specificity were 72.9% and 99.4% for the Humasis Ag-RDT and 64.7% and 100% for the PBCheck Ag-RDT, respectively. The sensitivity for specimens with Ct≤25 was 100% for both Ag-RDTs. The Humasis Ag-RDT showed no cross-reactivity with other respiratory pathogens. Conclusion. Our data suggests that the Humasis Ag-RDT can be a useful diagnostic tool for the detection of SARS-CoV-2 infection.
| Original language | English |
|---|---|
| Pages (from-to) | 126-130 |
| Number of pages | 5 |
| Journal | Annals of Clinical and Laboratory Science |
| Volume | 54 |
| Issue number | 1 |
| State | Published - Jan 2024 |
Keywords
- antigen rapid diagnostic test
- COVID-19
- Humasis
- PBCheck
- SARS-CoV-2